Exelixis | EXEL - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cytokinetics USD 8.19B 420M 2026-03
Eisai JPY 1.42T 110.62B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 10.89B 857M 2026-03
Genmab DKK 20.48B 1.02B 2025-12
Glaxosmithkline GBP 108.55B 736M 2026-07
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
MacroGenics USD 287M 103M 2026-07
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 307.76B 15.54B 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Sanofi EUR 108.52B 5B 2026-07
Takeda JPY 9.01T 1.37T 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Xencor USD 893M 200M 2026-03